Adiponectin alters renal calcium and phosphate excretion through regulation of klotho expression

Joseph M. Rutkowski, Johanne Pastor, Kai Sun, Sun K. Park, I. Alexandru Bobulescu, Christopher T. Chen, Orson W. Moe, Philipp E. Scherer

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The kidney controls systemic calcium and phosphate levels and disturbances of its control mechanisms can lead to a variety of diseases. The insulin-sensitizing adipokine adiponectin is renoprotective and accelerates functional recovery following renal injury. However, unlike other adipokines, adiponectin is reduced in obesity. High adiponectin levels are also correlated with bone loss, suggestive of an additional action in mineral metabolism. Using knockout, wild-type, and adiponectin-overexpressing transgenic mice, we sought to identify the mechanistic basis for adiponectin's ability to regulate calcium and phosphate balance at the level of the kidney. Adiponectin knockout mice exhibited lower serum calcium, lower urinary calcium excretion, and markedly lower serum fibroblast growth factor 23 (FGF23) levels, although circulating klotho concentrations were significantly higher than in wild-type littermates. The transgenic mice exhibited lower bone mass and strength, particularly compared to adiponectin knockout mice. The transgenic mice were hyper-responsive to a 2% phosphate-enriched diet, exhibiting 2-fold higher serum FGF23 and concomitantly higher fractional phosphate excretion. These mice also excreted more calcium with calcium-enriched diet and had less renal klotho protein expression. In contrast, the knockout mice exhibited a smaller increase in FGF23 and maintained elevated klotho levels on both mineral challenges. Kidney-specific adiponectin expression in doxycycline-inducible adiponectin mice and adiponectin addition . in vitro confirmed adiponectin's ability to reduce tubular epithelial cell klotho secretion. Thus, adiponectin alters calcium and phosphate balance and renal mineral excretion, in part, through klotho. This work highlights the profound effects of adipose tissue on renal function and has identified a new mechanism by which adiponectin may regulate bone mass.

Original languageEnglish (US)
JournalKidney International
DOIs
StateAccepted/In press - Dec 22 2015

Fingerprint

Adiponectin
Kidney
Knockout Mice
Transgenic Mice
Calcium
Minerals
Adipokines
Bone and Bones
calcium phosphate
Serum
Phosphates
Diet
Doxycycline
Adipose Tissue
Obesity
Epithelial Cells
Insulin

Keywords

  • Calcium
  • FGF23
  • Mineral metabolism
  • Obesity
  • Phosphate

ASJC Scopus subject areas

  • Medicine(all)
  • Nephrology

Cite this

Adiponectin alters renal calcium and phosphate excretion through regulation of klotho expression. / Rutkowski, Joseph M.; Pastor, Johanne; Sun, Kai; Park, Sun K.; Bobulescu, I. Alexandru; Chen, Christopher T.; Moe, Orson W.; Scherer, Philipp E.

In: Kidney International, 22.12.2015.

Research output: Contribution to journalArticle

@article{9e1d1505ac84417d9c89e78effa32a88,
title = "Adiponectin alters renal calcium and phosphate excretion through regulation of klotho expression",
abstract = "The kidney controls systemic calcium and phosphate levels and disturbances of its control mechanisms can lead to a variety of diseases. The insulin-sensitizing adipokine adiponectin is renoprotective and accelerates functional recovery following renal injury. However, unlike other adipokines, adiponectin is reduced in obesity. High adiponectin levels are also correlated with bone loss, suggestive of an additional action in mineral metabolism. Using knockout, wild-type, and adiponectin-overexpressing transgenic mice, we sought to identify the mechanistic basis for adiponectin's ability to regulate calcium and phosphate balance at the level of the kidney. Adiponectin knockout mice exhibited lower serum calcium, lower urinary calcium excretion, and markedly lower serum fibroblast growth factor 23 (FGF23) levels, although circulating klotho concentrations were significantly higher than in wild-type littermates. The transgenic mice exhibited lower bone mass and strength, particularly compared to adiponectin knockout mice. The transgenic mice were hyper-responsive to a 2{\%} phosphate-enriched diet, exhibiting 2-fold higher serum FGF23 and concomitantly higher fractional phosphate excretion. These mice also excreted more calcium with calcium-enriched diet and had less renal klotho protein expression. In contrast, the knockout mice exhibited a smaller increase in FGF23 and maintained elevated klotho levels on both mineral challenges. Kidney-specific adiponectin expression in doxycycline-inducible adiponectin mice and adiponectin addition . in vitro confirmed adiponectin's ability to reduce tubular epithelial cell klotho secretion. Thus, adiponectin alters calcium and phosphate balance and renal mineral excretion, in part, through klotho. This work highlights the profound effects of adipose tissue on renal function and has identified a new mechanism by which adiponectin may regulate bone mass.",
keywords = "Calcium, FGF23, Mineral metabolism, Obesity, Phosphate",
author = "Rutkowski, {Joseph M.} and Johanne Pastor and Kai Sun and Park, {Sun K.} and Bobulescu, {I. Alexandru} and Chen, {Christopher T.} and Moe, {Orson W.} and Scherer, {Philipp E.}",
year = "2015",
month = "12",
day = "22",
doi = "10.1016/j.kint.2016.09.016",
language = "English (US)",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Adiponectin alters renal calcium and phosphate excretion through regulation of klotho expression

AU - Rutkowski, Joseph M.

AU - Pastor, Johanne

AU - Sun, Kai

AU - Park, Sun K.

AU - Bobulescu, I. Alexandru

AU - Chen, Christopher T.

AU - Moe, Orson W.

AU - Scherer, Philipp E.

PY - 2015/12/22

Y1 - 2015/12/22

N2 - The kidney controls systemic calcium and phosphate levels and disturbances of its control mechanisms can lead to a variety of diseases. The insulin-sensitizing adipokine adiponectin is renoprotective and accelerates functional recovery following renal injury. However, unlike other adipokines, adiponectin is reduced in obesity. High adiponectin levels are also correlated with bone loss, suggestive of an additional action in mineral metabolism. Using knockout, wild-type, and adiponectin-overexpressing transgenic mice, we sought to identify the mechanistic basis for adiponectin's ability to regulate calcium and phosphate balance at the level of the kidney. Adiponectin knockout mice exhibited lower serum calcium, lower urinary calcium excretion, and markedly lower serum fibroblast growth factor 23 (FGF23) levels, although circulating klotho concentrations were significantly higher than in wild-type littermates. The transgenic mice exhibited lower bone mass and strength, particularly compared to adiponectin knockout mice. The transgenic mice were hyper-responsive to a 2% phosphate-enriched diet, exhibiting 2-fold higher serum FGF23 and concomitantly higher fractional phosphate excretion. These mice also excreted more calcium with calcium-enriched diet and had less renal klotho protein expression. In contrast, the knockout mice exhibited a smaller increase in FGF23 and maintained elevated klotho levels on both mineral challenges. Kidney-specific adiponectin expression in doxycycline-inducible adiponectin mice and adiponectin addition . in vitro confirmed adiponectin's ability to reduce tubular epithelial cell klotho secretion. Thus, adiponectin alters calcium and phosphate balance and renal mineral excretion, in part, through klotho. This work highlights the profound effects of adipose tissue on renal function and has identified a new mechanism by which adiponectin may regulate bone mass.

AB - The kidney controls systemic calcium and phosphate levels and disturbances of its control mechanisms can lead to a variety of diseases. The insulin-sensitizing adipokine adiponectin is renoprotective and accelerates functional recovery following renal injury. However, unlike other adipokines, adiponectin is reduced in obesity. High adiponectin levels are also correlated with bone loss, suggestive of an additional action in mineral metabolism. Using knockout, wild-type, and adiponectin-overexpressing transgenic mice, we sought to identify the mechanistic basis for adiponectin's ability to regulate calcium and phosphate balance at the level of the kidney. Adiponectin knockout mice exhibited lower serum calcium, lower urinary calcium excretion, and markedly lower serum fibroblast growth factor 23 (FGF23) levels, although circulating klotho concentrations were significantly higher than in wild-type littermates. The transgenic mice exhibited lower bone mass and strength, particularly compared to adiponectin knockout mice. The transgenic mice were hyper-responsive to a 2% phosphate-enriched diet, exhibiting 2-fold higher serum FGF23 and concomitantly higher fractional phosphate excretion. These mice also excreted more calcium with calcium-enriched diet and had less renal klotho protein expression. In contrast, the knockout mice exhibited a smaller increase in FGF23 and maintained elevated klotho levels on both mineral challenges. Kidney-specific adiponectin expression in doxycycline-inducible adiponectin mice and adiponectin addition . in vitro confirmed adiponectin's ability to reduce tubular epithelial cell klotho secretion. Thus, adiponectin alters calcium and phosphate balance and renal mineral excretion, in part, through klotho. This work highlights the profound effects of adipose tissue on renal function and has identified a new mechanism by which adiponectin may regulate bone mass.

KW - Calcium

KW - FGF23

KW - Mineral metabolism

KW - Obesity

KW - Phosphate

UR - http://www.scopus.com/inward/record.url?scp=85007448597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007448597&partnerID=8YFLogxK

U2 - 10.1016/j.kint.2016.09.016

DO - 10.1016/j.kint.2016.09.016

M3 - Article

JO - Kidney International

JF - Kidney International

SN - 0085-2538

ER -